Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:582-584
doi: 10.1161/01.RES.0000215564.22445.7e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischmeister, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischmeister, R.
Related Collections
Right arrowRelated Article
(Circulation Research. 2006;98:582.)
© 2006 American Heart Association, Inc.


Editorials

Is cAMP Good or Bad?

Depends on Where It’s Made

Rodolphe Fischmeister

From INSERM U769, Châtenay-Malabry, F-92296 France, and Université Paris-Sud, Faculté de Pharmacie, IFR141, Châtenay-Malabry, F-92286 France.

Correspondence to Rodolphe FISCHMEISTER, INSERM U769, Faculté de Pharmacie, 5, Rue J.-B. Clément, F-92296 Châtenay-Malabry Cedex, France. E-mail fisch@vjf.inserm.fr



See related article, pages 675–681


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Endothelium of the vascular system forms a semipermeable barrier between blood and the interstitial space that serves to control and restrict the luminal to abluminal movement of water, plasma proteins, and other solutes.1 During inflammation, mediators such as thrombin, histamine, and platelet activating factor (PAF) induce vascular leakage defined as an increased endothelial permeability to plasma proteins. In the lung, disruption of the barrier formed by pulmonary microvascular endothelial cells (PMVECs) occurs during inflammatory disease states such as acute lung injury and acute respiratory distress syndrome. Endothelial permeability to macromolecules occurs via the formation of small gaps between (paracellular) or through (transcellular) cells and is controlled by cell shape and cell adhesion through a balance of opposite mechanical forces; contractile forces generated by actomyosin motor function, tethering forces generated by adhesive proteins at the cell–cell border, and focal adhesions at the cell–matrix border.2 Because of its central role in mechanical processes, Ca2+ is an important regulator of endothelial permeability. Intracellular Ca2+ concentration ([Ca2+]i) is increased in PMVECs on binding of proinflammatory mediators to their respective membrane receptors, and subsequent activation of the Gq protein–mediated signaling cascade. In particular, this rise in [Ca2+]i is essential for the generation of endothelial cell paracellular gaps. Other downstream major actors in this Ca2+-sensitizing cascade include PKC, Ca2+-dependent myosin light chain kinase (MLCK), and the monomeric GTPase RhoA.

Whereas elevated [Ca2+]i increases endothelial barrier permeability, increased cAMP has the opposite effect.3 Changes in this ubiquitous second messenger are governed . . . [Full Text of this Article]


Related Article:

Soluble Adenylyl Cyclase Reveals the Significance of cAMP Compartmentation on Pulmonary Microvascular Endothelial Cell Barrier
Sarah L. Sayner, Mikhail Alexeyev, Carmen W. Dessauer, and Troy Stevens
Circ. Res. 2006 98: 675-681. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. C. Moore and Z. K. Ballas
A Novel Therapy for Lymphedema
Arch Intern Med, January 26, 2009; 169(2): 201 - 202.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. H. Adamson, J. C. Ly, R. K. Sarai, J. F. Lenz, A. Altangerel, D. Drenckhahn, and F. E. Curry
Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1188 - H1196.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Creighton, B. Zhu, M. Alexeyev, and T. Stevens
Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation
J. Cell Sci., January 1, 2008; 121(1): 110 - 119.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. D. Houslay, G. S. Baillie, and D. H. Maurice
cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling
Circ. Res., April 13, 2007; 100(7): 950 - 966.
[Abstract] [Full Text] [PDF]